PLG, vWF, and AOX1 are the three most protective hub genes for ccRCC patients, and ccRCC patients with a higher expression of these genes have 50% more overall survival advantage over those with a lower expression (Figure 3D). This evidence concerns the gene VWF and nonpapillary renal cell carcinoma.